Adverse reactions to iodinated contrast media administered at the time of endoscopic retrograde cholangiopancreatography (ERCP)

Inflammation and Allergy - Drug Targets

Volumn 8, Issue 1, 2009, Pages 17-20

  Pan, Jen Jung ^a   Draganov, Peter V ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Adverse reaction; Allergy; Endoscopic retrograde cholangiopancreatography; ERCP; Iodine contrast medium

Indexed keywords

DIPHENHYDRAMINE; HYDROCORTISONE; METHYLPREDNISOLONE; NONIONIC CONTRAST MEDIUM; PREDNISOLONE; PREDNISONE; STEROID;

ANAPHYLACTOID PURPURA; ARTHRALGIA; ARTICLE; BRONCHOSPASM; CONVULSION; DIARRHEA; DIZZINESS; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG DOSAGE FORM COMPARISON; DRUG FATALITY; DRUG INDUCED DISEASE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; EPIGASTRIC PAIN; EVIDENCE BASED PRACTICE; FEVER; FLUSHING; FOOD ALLERGY; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART ARREST; HEART ARRHYTHMIA; HUMAN; HYPOTENSION; INVASIVE PROCEDURE; LARYNX EDEMA; LUNG COLLAPSE; LUNG EDEMA; NAUSEA; OSMOLALITY; PAIN; PANCREAS DUCT; PROPHYLAXIS; PRURITUS; RADIOGRAPHY; RASH; RISK FACTOR; RISK REDUCTION; SEIZURE; SHOCK; SIDE EFFECT; SKIN MANIFESTATION; SYSTEMIC DISEASE; UNCONSCIOUSNESS; URINARY EXCRETION; URTICARIA; VOMITING;

ADRENAL CORTEX HORMONES; ANAPHYLAXIS; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CONTRAST MEDIA; DRUG HYPERSENSITIVITY; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; HUMANS; INCIDENCE; IODINE; RISK FACTORS;

EID: 70349484148     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152809787582480     Document Type: Article

References (40)

1. Bilbao, M.K.; Dotter, C.T.; Lee, T.G.; Katon, R.M. Complications of endoscopic retrograde cholangiopancreatography (ERCP). A study of 10,000 cases. Gastroenterology, 1976, 70, 314.
2. Moreira, V.F.; Merono, E.; Larraona, J.L.; Gonzalez, J.A.; Simon, M.A.; Fernandez, C.; Ruiz del Arbol, L. ERCP and allergic reactions to iodized contrast media. Gastrointest. Endosc., 1985, 31, 293.
3. Sahel, J.; Sarles, H. Endoscopic pancreatography and urograms. Gastroenterology, 1976, 71, 1109.
4. Goldberg, H.I.; Bilbao, M.K.; Stewart, E.T.; Rohrmann, C.A.; Moss, A.A. Endoscopic retrograde cholangiopancreatography (ERCP): radiographic technique. Am. J. Dig. Dis., 1976, 21, 270.
5. Sable, R.A.; Rosenthal, W.S.; Siegel, J.; Ho, R.; Jankowski, R.H. Absorption of contrast medium during ERCP. Dig. Dis. Sci., 1983, 28, 801.
6. Roszler, M.H.; Campbell, W.L. Post-ERCP pancreatitis: association with urographic visualization during ERCP. Radiology, 1985, 157, 595.
7. Ladas, S.D.; Rokkas, T.; Kaskarelis, J.; Hatzioannou, J.; Raptis, S. Absorption of iodized contrast media during ERCP. Gastrointest. Endosc., 1986, 32, 376.
8. Hopper, K.D.; Wegert, S.J.; Hallgren, S.E. Renal excretion of endoscopic retrograde cholangiopancreatography injected contrast. A common phenomenon. Invest. Radiol., 1989, 24, 394.
9. Mann, K.; Rendl, J.; Busley, R.; Saller, B.; Seybold, S.; Hoermann, R.; Sauerbruch, T.; Borner, W. Systemic iodine absorption during endoscopic application of radiographic contrast agents for endoscopic retrograde cholangiopancreaticography. Eur. J. Endocrinol., 1994, 130, 498.
10. Gmelin, E.; Kramann, B.; Weiss, H.D. Complication with contrast medium in endoscopic retrograde cholangiopancreaticography. MMW Munch. Med. Wochenschr., 1977, 119, 1439.
11. Mishkin, D.; Carpenter, S.; Croffie, J.; Chuttani, R.; DiSario, J.; Hussain, N.; Liu, J.; Somogyi, L.; Tierney, W.; Petersen, B.T. ASGE Technology Status Evaluation Report: radiographic contrast media used in ERCP. Gastrointest. Endosc., 2005, 62, 480.
12. Draganov, P.; Pan, J.-J.; Forsmark, C. Prospective evaluation of adverse reactions to iodine-containing contrast media (CM) after ERCP. Gastrointest. Endosc., 2008, 67, AB107.
13. Monig, H.; Arendt, T.; Eggers, S.; Kloehn, S.; Folsch, U.R. Iodine absorption in patients undergoing ERCP compared with coronary angiography. Gastrointest. Endosc., 1999, 50, 79.
14. Fassbender, W.J.; Vogel, C.; Doppl, W.; Stracke, H.; Bretzel, R.G.; Klor, H.U. Thyroid function, thyroid immunoglobulin status, and urinary iodine excretion after enteral contrast-agent administration by endoscopic retrograde cholangiopancreatography. Endoscopy, 2001, 33, 245.
15. Thomsen, H.S.; Bush, W.H. Jr. Adverse effects of contrast media: incidence, prevention and management. Drug Saf., 1998, 19, 313.
16. Draganov, P.; Cotton, P.B. Iodinated contrast sensitivity in ERCP. Am. J. Gastroenterol., 2000, 95, 1398.
17. Morcos, S.K.; Thomsen, H.S. Adverse reactions to iodinated contrast media. Eur. Radiol., 2001, 11, 1267.
18. Munechika, H.; Hiramatsu, Y.; Kudo, S.; Sugimura, K.; Hamada, C.; Yamaguchi, K.; Katayama, H. A prospective survey of delayed adverse reactions to iohexol in urography and computed tomography. Eur. Radiol., 2003, 13, 185.
19. American College of Radiology Committee on Drugs and Contrast Media. Manual on Contrast Media e: ACR, 2004.
20. Fischer, H.W.; Doust, V.L. An evaluation of pretesting in the problem of serious and fatal reactions to excretory urography. Radiology, 1972, 103, 497.
21. Witten, D.M. Reactions to urographic contrast media. JAMA, 1975, 231, 974.
22. Almen, T. The etiology of contrast medium reactions. Invest. Radiol., 1994, 29(Suppl 1), S37.
23. Siegle, R. Mechanisms of reactions to contrast media. In Dawson P, Cosgrove DO, Grainger RG (eds). Edited by Oxford, Isis Medical Media, 1999, 95.
24. Katayama, H.; Yamaguchi, K.; Kozuka, T.; Takashima, T.; Seez, P.; Matsuura, K. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology, 1990, 175, 621.
25. Davies, P.; Roberts, M.B.; Roylance, J. Acute reactions to urographic contrast media. Br. Med. J., 1975, 2, 434.
26. Shehadi, W.H. Contrast media adverse reactions: occurrence, recurrence, and distribution patterns. Radiology, 1982, 143, 11.
27. Yamaguchi, K.; Katayama, H.; Takashima, T.; Kozuka, T.; Seez, P.; Matsuura, K. Prediction of severe adverse reactions to ionic and nonionic contrast media in Japan: evaluation of pretesting. A report from the Japanese Committee on the Safety of Contrast Media. Radiology, 1991, 178, 363.
28. Lasser, E.C.; Berry, C.C.; Talner, L.B.; Santini, L.C.; Lang, E.K.; Gerber, F.H.; Stolberg, H.O. Pretreatment with corticosteroids to alleviate reactions to intravenous contrast material. N. Engl. J. Med., 1987, 317, 845.
29. Greenberger, P.A.; Patterson, R. J. The prevention of immediate generalized reactions to radiocontrast media in high-risk patients. Allergy Clin. Immunol., 1991, 87, 867.
30. Wolf, G.L.; Mishkin, M.M.; Roux, S.G.; Halpern, E.F.; Gottlieb, J.; Zimmerman, J.; Gillen, J.; Thellman, C. Comparison of the rates of adverse drug reactions. Ionic contrast agents, ionic agents combined with steroids, and nonionic agents. Invest. Radiol., 1991, 26, 404.
31. Osnes, M.; Skjennald, A.; Larsen, S. A comparison of a new nonionic (metrizamide) and a dissociable (metrizoate) contrast medium in endoscopic retrograde pancreatography (ERP). Scand. J. Gastroenterol., 1977, 12, 821.
32. Barkin, J.S.; Casal, G.L.; Reiner, D.K.; Goldberg, R.I.; Phillips, R.S.; Kaplan, S. A comparative study of contrast agents for endoscopic retrograde pancreatography. Am. J. Gastroenterol., 1991, 86, 1437.
33. Bedford, R.A.; Joshson, G. K.; Geenen J. E. Ionic versus non-ionic contrast media: Does stepwise therapy influence the incidence of post-ERCP pancreatitis. Gastroenterology, 1994, 104, A294.
34. Johnson, G.K.; Geenen, J.E.; Bedford, R.A.; Johanson, J.; Cass, O.; Sherman, S.; Hogan, W.J.; Ryan, M.; Silverman, W.; Edmundowicz, S. A comparison of nonionic versus ionic contrast media: results of a prospective, multicenter study. Midwest Pancreaticobiliary Study Group. Gastrointest. Endosc., 1995, 42, 312.
35. Pfau, P.R.; Mosley, R.G.; Said, A.; Gopal, D.V.; Fischer, M.C.; Oberley, T.; Weiss, J.; Lee, F.T. Jr.; Eckoff, D.; Reichelderfer, M. Comparison of the effect of non-ionic and ionic contrast agents on pancreatic histology in a canine model. JOP, 2006, 7, 27.
36. Kruse, A.; Brock, A.; Rodenberg, J.; Nowakowska-Duawa, E.; Bjartveit, K. Iopentol (Imagopaque 250) compared with diatrizoate (Urografin 219) in endoscopic retrograde cholangiopancreatography (ERCP). A clinical trial assessing safety (adverse events and S-pancreatic iso-amylase) and diagnostic information (VAS). Eur. Radiol., 1997, 7(Suppl 4), S131.
37. Maluf-Filho, F.; Rocha, M.S.; Sakai, P. Use of a neutral gadolinium chelate as a contrast medium for ERCP: case report. Gastrointest. Endosc., 2005, 61, 917.
38. Mosca, S.; Secondulfo, M.; Defez, M.; Calise, F. Air contrastography technique for successful urgent ERCP in a high risk allergic patient. Am. J. Gastroenterol., 2001, 96, 3458.
39. Poneros, J.M.; Tearney, G.J.; Shiskov, M.; Kelsey, P.B.; Lauwers, G.Y.; Nishioka, N.S.; Bouma, B.E. Optical coherence tomography of the biliary tree during ERCP. Gastrointest. Endosc., 2002, 55, 84.
40. Chen, Y.K.; Pleskow, D.K. SpyGlass single-operator peroral cholangiopancreatoscopy system for the diagnosis and therapy of bileduct disorders: a clinical feasibility study (with video). Gastrointest. Endosc., 2007, 65, 832.